Clarity Pharmaceuticals Ltd (CU6) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.271x

Based on the latest financial reports, Clarity Pharmaceuticals Ltd (CU6) has a cash flow conversion efficiency ratio of -0.271x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-24.46 Million ≈ $-17.31 Million USD) by net assets (AU$90.23 Million ≈ $63.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Clarity Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Clarity Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Clarity Pharmaceuticals Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Clarity Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clarity Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangsu Canlon Building Materials Co Ltd SHE:300715	0.003x
Suntront Tech SHE:300259	0.009x
Hefei Department Store Group Co Ltd SHE:000417	0.042x
Dongguan Golden Sun Abrasives Co Ltd SHE:300606	0.038x
Puyang Refractories Group Co Ltd SHE:002225	0.011x
AVALON TECHNOLOGIES LTD NSE:AVALON	0.018x
Yunnan Yunwei Co Ltd Class A SHG:600725	-0.040x
PHARMING GRP SP. ADRS F:PHG	N/A

Annual Cash Flow Conversion Efficiency for Clarity Pharmaceuticals Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of Clarity Pharmaceuticals Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Clarity Pharmaceuticals Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$90.23 Million ≈ $63.84 Million	AU$-54.77 Million ≈ $-38.75 Million	-0.607x	-105.38%
2024-06-30	AU$146.30 Million ≈ $103.51 Million	AU$-43.24 Million ≈ $-30.59 Million	-0.296x	+25.66%
2023-06-30	AU$69.18 Million ≈ $48.95 Million	AU$-27.50 Million ≈ $-19.46 Million	-0.398x	-175.41%
2022-06-30	AU$92.24 Million ≈ $65.26 Million	AU$-13.31 Million ≈ $-9.42 Million	-0.144x	+61.87%
2021-06-30	AU$20.28 Million ≈ $14.35 Million	AU$-7.68 Million ≈ $-5.43 Million	-0.379x	+54.78%
2020-06-30	AU$8.16 Million ≈ $5.77 Million	AU$-6.83 Million ≈ $-4.83 Million	-0.837x	-108.35%
2019-06-30	AU$9.23 Million ≈ $6.53 Million	AU$-3.71 Million ≈ $-2.62 Million	-0.402x	+48.30%
2018-06-30	AU$1.93 Million ≈ $1.37 Million	AU$-1.50 Million ≈ $-1.06 Million	-0.777x	--

About Clarity Pharmaceuticals Ltd

AU:CU6 Australia Biotechnology

Market Cap

$763.38 Million

AU$1.08 Billion AUD

Market Cap Rank

#10389 Global

#258 in Australia

Share Price

AU$2.90

Change (1 day)

+2.47%

52-Week Range

AU$1.90 - AU$5.70

All Time High

AU$8.79